6505-- Intent to Sole Source Xofigo - Radiopharmaceutical for Lebanon VAMC
ID: 36C24425Q0459Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF244-NETWORK CONTRACT OFFICE 4 (36C244)PITTSBURGH, PA, 15215, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/5c9b877373b343e18e150ffe28eac37f/view
Timeline
    Description

    The Department of Veterans Affairs intends to sole source a contract for the procurement of Xofigo (Radium 223 dichloride) for the Lebanon VA Medical Center. This procurement aims to fulfill the medical center's nuclear medicine requirements, ensuring the delivery, storage, and quality management of this critical radioisotope used in cancer treatment for patients with resistant prostate cancer. The contract is set for a duration of one year, beginning June 29, 2025, with interested vendors required to submit a one-page capability statement by March 13, 2025, at 10:00 AM EST. For further inquiries, vendors can contact Contract Specialist Christa Stine at christa.stine@va.gov or by phone at 570-824-3521.

    Point(s) of Contact
    Christa StineContract Specialist
    (570) 824-3521
    christa.stine@va.gov
    Files
    Title
    Posted
    36C24425Q0459.docx
    The Department of Veterans Affairs intends to sole source a contract for the procurement of Xofigo (Radium 223 dichloride) for the Lebanon VA Medical Center. This decision follows the authority provided under FAR 13.106-1, indicating a single-source justification with Cardinal Health 414, LLC. The procurement aims to meet the medical center’s nuclear medicine needs, including delivery, storage, and quality management of the radioisotope for cancer treatment. The contract is planned for a duration of one year, beginning June 29, 2025, with firm-fixed pricing. Interested vendors must submit a one-page capability statement by March 13, 2025, 10:00 AM EST, detailing their qualifications and ability to supply the required materials. Contractors must adhere to rigorous regulatory guidelines, possess appropriate licenses, and ensure all products meet quality standards. Delivery is mandatory for specific timeframes, and no additional charges for daytime deliveries are expected. The contract emphasizes compliance with federal regulations, including those governing radiation and health information. The Lebanon VA Medical Center is committed to ensuring a consistent supply of Xofigo for patients with resistant prostate cancer, highlighting the project's critical role in patient care.
    Lifecycle
    Title
    Type
    6505-- Intent to Sole Source Xofigo - Radiopharmaceutical for Lebanon VAMC
    Currently viewing
    Special Notice
    Similar Opportunities
    6505-- Nuclear Medicine Radiopharmaceuticals
    Buyer not available
    The Department of Veterans Affairs is issuing a Request for Quotations (RFQ) for the procurement of nuclear medicine radiopharmaceuticals required at the Captain James A. Lovell Federal Health Care Center in North Chicago, IL. The contract will cover the supply of various specified radiopharmaceuticals over a base year from April 1, 2025, to March 31, 2026, with options for four additional years, emphasizing compliance with regulatory standards and quality control measures. These radiopharmaceuticals are critical for diagnostic testing and quality assurance in medical settings, ensuring accurate and safe patient care. Interested suppliers must submit their responses by March 12, 2025, at 12:00 p.m. CST, and can direct inquiries to the contracting officer, Tiffany Pevey, via email at Tiffany.Pevey@va.gov.
    Radiopharmaceuticals - Naval Medical Center Portsmouth
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is soliciting proposals for the procurement of radiopharmaceuticals to support cancer treatment at the Naval Medical Center Portsmouth. The contract aims to secure a supply of various medical imaging agents, including Tc-99m isotopes, I-123, and F-18 compounds, essential for diagnostic imaging and therapeutic applications, over a five-year period from April 1, 2025, to March 31, 2030, with options for renewal. This procurement is critical for ensuring the availability of necessary medical supplies within the military healthcare system, emphasizing compliance with safety regulations and cost-effectiveness. Interested vendors, particularly small businesses, are encouraged to submit proposals by March 11, 2025, and can contact Carol Uebelacker at carol.e.uebelacker.civ@health.mil or 210-952-8111 for further information.
    6505--Radiopharmaceuticals For The Portland VA Medical Center
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of radiopharmaceuticals for the Portland VA Medical Center. This opportunity, identified by solicitation number 36C26025Q0237, aims to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract to supply essential nuclear medicine supplies, ensuring 24/7 availability and prompt delivery for patient care. The procurement is particularly significant as it supports the medical needs of veterans while promoting participation from Service-Disabled Veteran-Owned Small Businesses (SDVOSB). Interested vendors must submit their proposals by March 28, 2025, at 13:00 Pacific Time, and can direct inquiries to José Ronstadt at jose.ronstadt@va.gov or by phone at 360-852-9885.
    6509--Solifenacin Tabletes (VA-25-00037090)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, designated as RFP 36E79725R0020. This procurement aims to establish a reliable supply of Solifenacin for the VA, Department of Defense (DoD), and other federal health agencies, with the contract expected to last one year and include four optional renewal periods. Solifenacin is a critical medication used in the treatment of overactive bladder, highlighting the VA's commitment to ensuring access to essential pharmaceuticals for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the RFP release, anticipated around March 14, 2025, with proposals due by March 28, 2025; for further inquiries, they may contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--Rituximab and Biosimilars
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Rituximab 10mg/ml and its biosimilars, aimed at establishing a reliable pharmaceutical supply source for government healthcare facilities. Bidders are required to provide unique National Drug Code (NDC) numbers for their products and include a 0.5% Cost Recovery Fee in their pricing, with the contract covering a base year and four optional subsequent years. This procurement is critical for ensuring consistent product availability and pricing based on estimated annual usage, while adhering to FDA regulations and the Drug Supply Chain Security Act (DSCSA) for safety and traceability. Interested suppliers must submit their proposals by March 11, 2025, at 2:30 PM CT, and can contact Contract Specialist Deborah S Fassl at Deborah.Fassl@va.gov for further information.
    6515--FVA Hot Lab Equipment
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of Hot Lab Equipment for the Nuclear Medicine Department at the Fredericksburg Health Care Center in Virginia. This Request for Proposal (RFP) is specifically set aside for small businesses, requiring contractors to be verified as such at the time of quote submission and award. The procurement includes essential items such as dose calibrators and lead-lined cabinets, with detailed specifications and delivery requirements outlined, emphasizing the importance of minimal disruption to ongoing operations during installation. Interested vendors should contact Contract Specialist Stephen M. Nassan at Stephen.Nassan@va.gov for further details, as adherence to contract clauses and regulations is mandatory throughout the process.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6515-- Scintillation Counter
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of a Scintillation Counter System, specifically the TRI-CARB LSC 4810TR model, intended for use at the Fredericksburg Health Care Center. This solicitation includes the delivery of the counter along with essential supplies such as standard vials and a utility cart, with an emphasis on installation, training, and compliance with security protocols. The acquisition is crucial for enhancing the analytical capabilities of the healthcare facility, thereby improving the quality of care provided to veterans. Interested vendors should note that the expected delivery period is between March 14, 2025, and April 30, 2025, and can direct inquiries to Contract Specialist Cedric Frasier at cedric.frasier@va.gov.
    6505--Carvedilol Tablets (VA-25-00048048)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carvedilol Tablets under solicitation number 36E79725R0028, aimed at ensuring a continuous supply for various federal health care entities, including the Department of Defense and the Bureau of Prisons. The contract will be for one year, with the possibility of four additional one-year extensions, requiring offerors to supply drugs labeled with their unique National Drug Code (NDC) without altering existing labels. This procurement is critical for maintaining the availability of essential medications for veterans and affiliated populations, underscoring the VA's commitment to effective health care delivery. Interested bidders should monitor SAM.gov for updates, with the RFP expected to be issued around March 19, 2025, and responses due by April 2, 2025; inquiries can be directed to Contract Specialist Adrienne Albachiara at adrienne.albachiara@va.gov or by phone at 708-202-9027.
    Q301--Lab Equipment Radiopharm | Brand Name Only-BioRad Quality Altoona VAMC
    Buyer not available
    The Department of Veterans Affairs is seeking to procure BioRad Quality Controls for the Altoona VA Medical Center, specifically for use with Abbott Alinity blood analyzers. The objective of this procurement is to ensure the availability of reliable quality control materials necessary for accurate testing and disease diagnosis, thereby enhancing patient care. This acquisition is critical as it emphasizes the need for consistent lot numbers and extended expiration dates to maintain the integrity of laboratory results. Interested vendors must submit their proposals by March 18, 2025, and can contact Contract Specialist Christa Stine at christa.stine@va.gov or 570-824-3521 for further information. The estimated total cost for this five-year contract is $184,072.50.